Skip to main content

Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAEZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced that two articles have been published back-to-back in the same issue of The Lancet Haematology. The articles detail data from the two randomized Phase 2 studies, CHAPTER-1 and RAPIDe-1, evaluating the efficacy and safety of deucrictibant, a potent, orally bioavailable small-molecule bradykinin B2 receptor antagonist,...

Continue reading

BitFuFu Announces Unaudited 2025 Full-Year Financial Results

SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the full year ended December 31, 2025. Full Year 2025 Financial HighlightsTotal revenue was $475.8 million in 2025, representing an increase of 2.7% from $463.3 million in 2024. The year-over-year increase was driven by higher revenue from Cloud Mining Solutions, Mining Equipment Sales, and Other, partially offset by a decline in revenue from Self-Mining Operations.    For the Year Ended December 31,      2025   2024Business Segment ($ in millions)   Revenue   % ofRevenue   Revenue   % ofRevenueCloud Mining Solutions   $      350.6     73.7 %     $       271.0     58.5 %  Self-Mining Operations     63.1     13.3 %       157.5     34.0 %  Mining...

Continue reading

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share

SAN JUAN CAPISTRANO, Calif., March 20, 2026 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before April 30, 2026, to shareholders of record as of March 31, 2026. Ensign has been a dividend-paying company since 2002. About Ensign™ The Ensign Group, Inc.’s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services...

Continue reading

OSB GROUP PLC – Block Application for Admission to Trading

LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the Company) Block Application for Admission to Trading A block application has been made to the London Stock Exchange for a total of 500,000 Ordinary Shares of £0.01 each (the Shares) to be admitted to trading. The Shares shall rank equally with the existing issued Shares of the Company. Admission is expected on or around 24 March 2026. Shares will be allotted from time to time following the exercise of options pursuant to the Company’s Deferred Share Bonus Plan. Enquiries:OSB GROUP PLCJess PetrieGroup Head of Corporate Governance        t: 01634 835 796 BrunswickRobin Wrench / Simone Selzer                                t: 020 7404 5959 Notes to Editors About OSB GROUP PLCs OSB began trading as a bank on 1 February 2011 and was admitted to the main market of the London Stock Exchange in June...

Continue reading

Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 million Breathe Right is an iconic and category‑leading brand with strong margins and cash flow generation Acquisition reinforces Prestige’s long-term organic growth algorithm Transaction expected to close in Prestige’s first half fiscal 2027TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that it has entered into a definitive agreement to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million. Breathe Right®, created in the 1990s, is an iconic #1 brand synonymous with the nasal strip category and...

Continue reading

Digitalage Introduces Stateful Media Infrastructure: The Architecture That Converts Every Live Stream Into a Permanent, Searchable, Monetizable Asset at Creation

Hop-on, Inc. (OTCID: HPNN) Defines the Category, Documents the Proof, and Positions as the Only Production Platform Operating Within It In simple terms: every live stream on Digitalage becomes a permanent, searchable, monetizable asset the moment it starts. That is Stateful Media Infrastructure. A technical and economic reclassification of what media is, how it works, and who captures value from it. The company that controls this infrastructure layer controls the economic foundation beneath the entire creator economy. Digitalage has built it, deployed it, and put it on the public record. TEMECULA, Calif., March 20, 2026 (GLOBE NEWSWIRE) — Hop-on, Inc. (OTCID: HPNN), through its subsidiary Digitalage, today introduced Stateful Media Infrastructure: a new infrastructure category and the framework beneath three sequential public milestones...

Continue reading

Subsea7 Annual Report 2025

Luxembourg – 20 March 2026 – Subsea  7 S.A.  (Oslo  Børs:  SUBC, ADR: SUBCY) announced today the publication of the Annual Report containing the Consolidated Financial  Statements  for  the  Subsea7  Group  and the Financial Statements of Subsea 7 S.A., the Parent Company, for the year ended 31 December 2025. The  Annual Report –  in PDF and  European Single Electronic  Format (ESEF) – is attached  to  this  press  release  and  also  available on the Group’s website, subsea7.com. *******************************************************************************Subsea7 is a global leader in the delivery of offshore projects and services for the evolving energy industry, creating sustainable value by being the industry’s partner and employer of choice in delivering the efficient offshore solutions the world needs. Subsea7...

Continue reading

Form 8.3 – [AFENTRA PLC – Opening Disclosure – 19 03 2026] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree AFENTRA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

SalMar – update of issuer credit rating from Nordic Credit Rating

Nordic Credit Rating has today, 20 March 2026, updated its issuer credit rating of SalMar ASA and assigned the company BBB with stable outlook. “Our ‘BBB’ long-term issuer credit rating on Norway-based salmon farmer SalMar ASA reflects the company’s strong profitability and moderate financial leverage” See link for more information: https://nordiccreditrating.com/issuer/salmar-asa For more information, please contact:Håkon Husby, Head of IRTel: +47 936 30 449Email: hakon.husby@salmar.no

Continue reading

Form 8.3 – [IDOX PLC – 19 03 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.